Press Releases

OntoMed and the Department of Cardiology of the Ospedale Sacro Cuore are commencing a study having as objective the evaluation of the recently launched OntoCare™ system. OntoCare™ is a software tool which quantifies the impact of therapy based on complexity analysis of patient's pre and post-therapy data. "In the case of Cardiac Resynchronisation Therapy via ICD implant for example, OntoCare™ allows us to express in quantitative terms the degree of success of therapy based on pre and post implant ECG analysis" said Dr. J. Marczyk, OntoMed's founder and CEO. OntoCare™ can be used to measure the degree of patient response to other forms of treatment, such as surgery, and provides in an easily understandable graphical form a breakdown into components of the impact on the patient's post-therapy state. Obtain the OntoCare™ Data Sheet here.

OntoMed is a US-based spin-off from Ontonix. Created in mid-2009, the company has the mission of delivering complexity concepts and technology to the medical community.

The Ospedale Sacro Cuore is based in Negrar, Verona, Italy. For more information visit website.

For additional information on OntoMed and its services, visit http://www.onto-med.com or write to us at info@ontonix.com.

OntoMed receives the TiE Midwest 20 Industry Award in the software segment

Dearborn MI, Oct 29, 2010

OntoMed LLC was awarded a Top 5 place in the software segment of the TiE Midwest 20 Industry Awards. The award was received by Dr. Bala Deshpande, co-founder and Chief Operating Officer of OntoMed LLC at the TiECON 2010 MidWest Conference organized by TiE Detroit.

TiE Detroit is the Detroit Chapter of The Indus Entrepreneurs, a not-for-profit organization that represents a diverse set of industries, including information technology, manufacturing, financial services and other emerging markets. There are currently over 12,000 members and more than 1,800 charter members in 53 chapters across 12 countries.

OntoMed (www.onto-med.com) is the US based healthcare focused spin-off from Ontonix (www.ontonix.com) which develops complexity management technology. “This award is a unique honor for our young company. It demonstrates our commitment to advancing technology adoption in the rapidly growing area of patient safety using data analytics” said Dr. Deshpande. OntoMed is currently collaborating with major hospitals and research institutions in the United States and Europe to establish the capabilities of their solution in critical care. For more information write to OntoMed at info@onto-med.com.
Source: OntoMed LLC.

OntoMed Launches OntoCare, a Therapy Impact Quantification System.

Ann Arbor, September 23-rd 2010. OntoMed launches OntoCare™, a software system which quantifies the impact of therapy based on complexity analysis of patient's pre and post-therapy data. "In the case of Cardiac Resynchronisation Therapy via ICD implant for example, OntoCare™ allows us to express in quantitative terms the degree of success of therapy based on pre and post implant ECG analysis" said Dr. J. Marczyk, OntoMed's co-founder and CEO. OntoCare™ can be used to measure the degree of patient response to other forms of treatment, such as surgery, and provides in an easily understandable graphical form a breakdown into components of the impact on the patient's post-therapy state. Obtain the OntoCare™ Data Sheet here.

OntoMed is a spin-off from Ontonix. Created in mid-2009, the company has the mission of delivering complexity concepts and technology to the medical community.

For additional information on OntoMed and its services, visit http://www.onto-med.com or write to us at info@onto-med.com.

OntoMed Signs Collaboration Agreement with US Army Institute of Surgical Research

Ann Arbor, MI. May 24, 2010: OntoMed, the healthcare focused spin off from Ontonix, has signed a Co-operative Research And Development Agreement (CRADA) with the U.S Army Institute of Surgical Research (USAISR) based in Fort Sam Houston, Texas. This CRADA represents an important milestone in OntoMed’s endeavor to deploy complexity analysis technology in the health care space. OntoMed develops COSMOS, a multi-channel real-time system which quantifies the stability of hospitalized patients. Based on streaming data, originating from sensors and other monitoring devices such as those in an Intensive Care Unit, the device measures the instantaneous degree of stability of a patient. The system also signals when the mentioned stability undergoes changes due to traumas, side-effects of treatment or any other dynamic mutations within the patient’s organism. The technology is unique in that it processes simultaneously all channels, analyzing all the cross-relationships, delivering a truly holistic view of the patient's state. Most importantly, since the collected data is processed by the system according to a model-free technique, the measure of stability of the patient is not biased by any particular mathematical approach. Ontonix, a privately held company, develops software and offers high added value services in the field of complexity management. OntoSpace™, the company's flagship product, is the world's first complexity quantification and management system. The unique approach to complexity and its quantification that is available in OntoSpace™ establishes radically innovative means of crisis-anticipation, superior BI-CPM, decision-making, holistic risk rating and risk management. Ontonix also offers a first-of-a-kind on-line on-demand service which enables our customers to purchase personalized Complexity & Risk Maps™ and perform near real-time complexity-based self-ratings, allowing one to verify the state-of-health of corporations, organizations, asset portfolios, or any kind of business. For additional information on Ontonix and its services, visit http://www.ontonix.com or write to us at info@ontonix.com.

OntoMed signs collaboration agreement with University of Michigan Health System

Ann Arbor, MI. February 15, 2010: OntoMed, the healthcare focused spin off from Ontonix (www.ontonix.com), has signed a data transfer and collaboration agreement with the University of Michigan Health System.

Under this agreement, OntoMed will be provided access to certain de-identified ICU data with the objective of quantifying the state of health and stability of patients under treatment. In return, UMHS will be able to utilize OntoMed’s complexity analysis expertise to explore the efficacy of this new technology for obtaining early alerts on the state of health of patients under critical care.

This collaboration represents an important milestone in OntoMed’s endeavor to deploy complexity analysis technology in the health care space.

OntoMed develops COSMOS, a multi-channel real-time device which quantifies the stability of hospitalized patients. Based on streaming data, originating from sensors and other monitoring devices such as those in an Intensive Care Unit, the device measures the instantaneous degree of stability of a patient. The system also signals when the mentioned stability undergoes changes due to traumas, side-effects of treatment or any other dynamic mutations within the patient’s organism. The technology is unique in that it processes simultaneously all channels, analyzing all the cross-relationships, delivering a truly holistic view of the patient's state. Most importantly, since the collected data is processed by the system according to a model-free technique, the measure of stability of the patient is not biased by any particular mathematical approach.

Ontonix, a privately held company, develops software and offers services in the field of complexity management. Ontonix also offers a first-of-a-kind on-line on-demand service which enables customers to purchase personalized Complexity & Risk Maps™ and perform near real-time self-ratings, allowing one to verify the state-of-health of corporations, organizations, asset portfolios, or any kind of business.

Ontomed launches COSMOS - a PC based patient stability monitor

Ann Arbor, MI, September 30, 2009: Ontomed, a company with the mission of delivering complexity technology to the medical community, announces the launch of their path-breaking patient stability monitor - COSMOS™ (COmplexity-based Stability MOnitoring System) a PC-based multi-channel real-time device which quantifies the stability of hospitalized patients. Based on streaming data, originating from sensors and other monitoring devices such as those in an Operating Room or an Intensive Care Unit or on the hospital floor, the device measures the instantaneous degree of stability of a patient. The system also signals when the mentioned stability undergoes changes due to traumas, side-effects of treatment or any other dynamic mutations within the patient’s organism. The device is unique in that it processes simultaneously all channels, analyzing all the cross-relationships, delivering a truly holistic view of the patient's state. Most importantly, since the collected data is processed by the system according to a model-free technique, the measure of stability of the patient is not flawed by any particular mathematical approach.

Ontomed is currently conducting large scale clinical trials with this state-of-the-art device in collaboration with the country's top research hospitals. Ontomed is also inviting medical centers and hospitals to evaluate out our monitoring system free for a limited period. To find out more write to info@onto-med.com. Ontomed is headquartered in Ann Arbor, Michigan.

Powered By Unosoft Technologies Copyright 2009 OntoMed. All rights reserved. Terms and Conditions